A new organization blessed by the president is raising money for events and projects that will put a Trumpian spin on the nation’s semiquincentennial. By Kenneth P. Vogel Lisa Friedman and David A.

Strive Compounding Pharmacy filed a federal antitrust lawsuit Jan. 14 against Eli Lilly and Novo Nordisk, alleging the two drugmakers used their market power to restrict access to compounded GLP-1 ...

Monday - Friday, 6:00 - 7:00 PM ET In a Monday interview with CNBC's Jim Cramer, Novo Nordisk CEO Mike Doustdar suggested the pharmaceutical giant's new pill format of its weight loss drug will allow ...

Abstract: Distributed optimization provides a framework for deriving distributed algorithms for a variety of multi-robot problems. This tutorial constitutes the first part of a two-part series on ...

Suzuki Motorcycle India has launched its first electric scooter in the Indian market called the e-Access. Introduced at Rs 1.88 lakh (ex-showroom), the electric two-wheeler will be manufactured at the ...

The Suzuki e-Access has a claimed range of just 95km on a single full charge. Suzuki starts bookings for its first electric scooter, e-Access, priced at Rs 1,88,490. e-Access has a 3.07kWh LFP battery ...

Suzuki has opened bookings for its first electric scooter, the Suzuki e-Access, marking the brand’s entry into the Indian electric two-wheeler market. We reviewed the e-Access early last year and the ...

Suzuki has finally launched the e-Access electric scooter in India at a surprising price of Rs 1,88,490 (ex-showroom, Delhi). Bookings are now open across all authorised Suzuki dealerships in the ...

BENGALURU: Space engineering firm Dhruva Space Thursday announced Polar Access-1 (PA-1), its most integrated launch programme so far, under which it will support 10 space missions serving multiple ...

NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight health, today announced access to Novo Nordisk’s newly ...

The CMS Innovation Center has debuted a new model to encourage the use of technology to treat chronic diseases, which could be a boon for health tech companies that have struggled with reimbursement.